News

Trends towards improvement in the key neurological endpoint were however identified by a meta-analysis of all Santhera’s Phase II and III studies in the same indication. MICONOS also

The pilot study with to-BBB is expected to allow researchers of Janssen to investigate the capabilities of the G-Technology to enhance delivery of their investigational compounds to the

COTI Phase 1 results showed that the majority of currently marketed and developmental stage HIV Integrase inhibitors have a very similar way of interacting with and inhibiting the

Trius said that it may receive up to $29.5m in support of development efforts under the new DTRA contract, which is funded as part of DTRA’s Transformational Medical

Medtronic RESCUE (Evaluation of the Clinical PeRformanceE of the Valiant Thoracic Stent Graft with the Captivia Delivery System for the EndovaSCUlar TrEatment of Blunt Thoracic Aortic Injuries) clinical

Hybrigenics said that the clinical tolerance observed at high and frequent exposure to Inecalcitol is positive. This makes it possible to consider other potential therapeutic indications such as

Abbott said that the latest approval for the Prism analyzer marks the completion of its full menu of blood screening tests, which includes assays for hepatitis, HIV and

Reportedly, Ablynx had signed the research collaboration and license agreement with Pfizer (originally signed with Wyeth Pharmaceuticals) in November 2006, a deal potentially worth $212.5m in past and

Galapagos claimed that GLPG0492 is an orally available small molecule that has been developed in its Selective Androgen Receptor Modulator (SARM) program. The candidate drug has been shown